Pfizer Enterprises

Pfizer is one of the world's largest research-based biopharmaceutical companies, engaged in the discovery, development, and manufacturing of healthcare products. The company's extensive portfolio includes blockbuster medicines and vaccines across therapeutic areas such as oncology, cardiology, immunology, and rare diseases. Pfizer gained significant global prominence for developing Comirnaty, the first authorized mRNA-based COVID-19 vaccine, in partnership with BioNTech. Following the 2023 acquisition of Seagen, Pfizer has significantly expanded its oncology pipeline, particularly in antibody-drug conjugates (ADCs). The company operates a massive global infrastructure for R&D and manufacturing, serving patients in over 125 countries.